跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abirasun - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abirasun
Approved
STANDARD
Abirasun
Sun Pharmaceutical Industries Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
87f33c20411ed2e0
Company
Sun Pharmaceutical Industries Limited
Type
Standard
Approval Details
Approval Id
87f33c20411ed2e0
Drug Approval Philippines Name
Abirasun
Product Name
Abirasun
Registration Number
DR-XY48435
Brand Name
Abirasun
Generic Name
Abiraterone acetate
Dosage Form
Tablet
Dosage Strength
250 mg
Manufacturer
Sun Pharmaceutical Industries Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Issuance Date
24 May 2024
Expiry Date
08 July 2027
Pharmacologic Category
Antineoplastic/Immunomodulating Agent (Hormone Antagonist/Related Agent)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
87f33c20411ed2e0
Type
Standard
Back to Philippines FDA Approvals